Cargando…
Chemotherapy-Induced Neutropenia in HIV Positive Patients with Lymphoma: Comparison of Pegfilgrastim with Daily Filgrastim Administration
We retrospectively compared the incidence of neutropenia in two groups of HIV patients with lymphoma, who underwent chemotherapy supported by once-per-cycle administration of pegfilgrastim or by daily subcutaneous injection of filgrastim, respectively. Our findings indicate that pegfilgrastim and fi...
Autores principales: | Teofili, Luciana, Izzi, Immacolata, Nuzzolo, Eugenia Rosa, Scoppettuolo, Giancarlo, Torti, Lorenza, Rossi, Marianna, de Gaetano Donati, Katleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500000/ https://www.ncbi.nlm.nih.gov/pubmed/23170191 http://dx.doi.org/10.4084/MJHID.2012.062 |
Ejemplares similares
-
The Safety Profile of Filgrastim and Pegfilgrastim
por: Neumann, Theresa A., et al.
Publicado: (2011) -
Meta-analysis and indirect treatment comparison of lipegfilgrastim
with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced
neutropenia-related events
por: Bond, T Christopher, et al.
Publicado: (2017) -
Pegfilgrastim Versus Filgrastim for Primary Prophylaxis of Febrile Neutropenia in Patients with non-Hodgkin’s Lymphoma: A Cost-Effectiveness Study
por: Ravangard, Ramin, et al.
Publicado: (2017) -
Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review
por: Gebremariam, Girma Tekle, et al.
Publicado: (2022) -
A randomized, double‐blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma
por: Kubo, Kohmei, et al.
Publicado: (2016)